Theratechnologies Inc (THTX)
1.23
+0.03
(+2.50%)
USD |
NASDAQ |
May 09, 11:57
Theratechnologies Profit Margin (Quarterly): -27.58% for Feb. 29, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | -27.58% |
November 30, 2023 | -11.75% |
August 31, 2023 | -3.58% |
May 31, 2023 | -57.06% |
February 28, 2023 | -52.46% |
November 30, 2022 | -37.02% |
August 31, 2022 | -36.27% |
May 31, 2022 | -118.0% |
February 28, 2022 | -48.67% |
November 30, 2021 | -52.79% |
August 31, 2021 | -53.27% |
May 31, 2021 | -35.94% |
February 28, 2021 | -38.38% |
November 30, 2020 | -29.02% |
August 31, 2020 | -48.17% |
May 31, 2020 | -33.83% |
February 29, 2020 | -28.91% |
November 30, 2019 | -39.36% |
August 31, 2019 | -10.17% |
May 31, 2019 | -20.33% |
February 28, 2019 | -8.13% |
November 30, 2018 | -7.03% |
August 31, 2018 | 2.09% |
May 31, 2018 | -19.92% |
February 28, 2018 | -25.72% |
Date | Value |
---|---|
November 30, 2017 | -32.81% |
August 31, 2017 | -25.69% |
May 31, 2017 | -90.94% |
February 28, 2017 | -24.83% |
November 30, 2016 | 1.72% |
August 31, 2016 | 9.95% |
May 31, 2016 | -5.52% |
February 29, 2016 | -1.75% |
November 30, 2015 | 5.42% |
August 31, 2015 | 12.82% |
May 31, 2015 | 11.24% |
February 28, 2015 | -20.00% |
November 30, 2014 | -132.9% |
August 31, 2014 | -109.8K% |
May 31, 2014 | 42.08% |
February 28, 2014 | -211.4% |
November 30, 2013 | -215.4% |
August 31, 2013 | -88.88% |
May 31, 2013 | -59.29% |
February 28, 2013 | |
November 30, 2012 | -111.3% |
August 31, 2012 | -18.26% |
May 31, 2012 | -53.35% |
February 29, 2012 | -234.6% |
November 30, 2011 | -21.07% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-118.0%
Minimum
May 2022
-3.58%
Maximum
Aug 2023
-39.13%
Average
-36.64%
Median
Profit Margin (Quarterly) Benchmarks
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | -59.60% |
Edesa Biotech Inc | -- |
Lexaria Bioscience Corp | -448.0% |
InMed Pharmaceuticals Inc | -119.2% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -25.38% |
Return on Invested Capital | -62.97% |
Gross Profit Margin (Quarterly) | 67.48% |
Operating Margin (Quarterly) | -13.82% |
Return on Net Operating Assets | -28.93% |